Stability of a high-concentration monoclonal antibody solution produced by liquid–liquid phase separation

Subcutaneous injection of a low volume (<2 mL) high concentration (>100 mg/mL) formulation is an attractive administration strategy for monoclonal antibodies (mAbs) and other biopharmaceutical proteins. Using concentrated solutions may also be beneficial at various stages of bioprocessing. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Bramham, Jack E., Davies, Stephanie A., Podmore, Adrian, Golovanov, Alexander P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265796/
https://www.ncbi.nlm.nih.gov/pubmed/34225583
http://dx.doi.org/10.1080/19420862.2021.1940666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265796/
https://www.ncbi.nlm.nih.gov/pubmed/34225583
http://dx.doi.org/10.1080/19420862.2021.1940666

Ejemplares similares